Life Sciences & Healthcare

The COVID-19 pandemic exposed a glaring disparity in global vaccine access. The World Economic Forum (WEF) and Deloitte have been collaborating to tackle this challenge by advocating for regionalised vaccine manufacturing ecosystems. This approach aims to revolutionise vaccine production and distribution, promoting equity and resilience in the face of future health crises.

From digital health to biotech and from digital therapeutics to healthcare IT innovations, there’s a community and a conversation about it at HLTH Europe Events.

Measuring the return from pharmaceutical innovation - 14th edition

The global healthcare sector is undergoing a period of unprecedented transformation, driven by technological advancements, demographic shifts and evolving patient needs. In 2024, several key trends are poised to shape the future of healthcare delivery. How can sector leaders and stakeholders prepare themselves for this profound change?

Deloitte is honoured to be one of a growing list of 60+ signatories of the Zero Health Gaps Pledge, the first global, multi-sector, CEO-level pledge to help advance health equity.

Learn more about the specific actions the Deloitte Health Equity Institutes are taking to foster health equity for all.

Innovating and collaborating for tomorrow

The critical success factors identified in 2020 remain paramount. But now stakeholders need to act on the lessons learnt to strengthen the collective ability to respond to or—better yet—proactively address the existing global health Issue.

A Deloitte and World Economic Forum report

Artificial intelligence-enabled technologies are transforming the different parts of the biopharma industry value chain, creating new business opportunities. Explore Deloitte's collection of content surrounding biopharma industry trends with a focus on AI in biopharma.